October 2, 2007
Edward Gershburg, Ph.D., has joined the faculty at Southern Illinois University School of Medicine as an assistant professor of medical microbiology, immunology and cell biology and research member of the SimmonsCooper Cancer Institute at SIU.
Most recently, he was on faculty at the University of North Carolina (UNC) at Chapel Hill (2005-07). Previously, he was a research associate at Lineberger Comprehensive Cancer Center at UNC (2002-05) and research engineer for the Institute of Plant Protection at the Volcani Center in Bet-Dagan, Israel (1993-94).
Gershburg earned his doctorate in virology at Tel-Aviv University in Israel (1999) and his master’s in microbiology at St. Petersburg State University in Russia (1992).
His memberships include the American Society for Microbiology, American Society for Virology, International Society for Antiviral Research, and International Association for Research on Epstein-Barr Virus (EBV) and Associated Diseases. He has published 16 journal articles. His research interest is in a member of herpes virus group, EBV, and its effects on immunosuppressed patients.
Gershburg is currently a co-investigator of a grant funded by the National Institutes of Health to study how new EBV therapies can be used for treating cancer malignancies. He will continue his research at SIU in collaboration with Joseph Pagano, M.D., professor of cancer research, medicine and microbiology and immunology and director emeritus, UNC Lineberger Comprehensive Cancer Center at the UNC.
A native of Uzbekistan, Gershburg and his wife, Svetlana Gershburg, have two children.